Global Generic Drugs Market Growth (Status and Outlook) 2022-2028
As the global economy mends, the 2021 growth of Generic Drugs will have significant change from previous year. According to our latest study, the global Generic Drugs market size is USD million in 2022 from USD 306650 million in 2021, with a change of % between 2021 and 2022. The global Generic Drugs market size will reach USD 546690 million in 2028, growing at a CAGR of 8.6% over the analysis period.
The United States Generic Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Generic Drugs market, reaching US$ million by the year 2028. As for the Europe Generic Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Generic Drugs players cover Teva, Novartis - Sandoz, Mylan, and Sun Pharmaceutical, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Generic Drugs market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Prescription
Non-Prescription Drugs
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospital
Clinic
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Teva
Novartis - Sandoz
Mylan
Sun Pharmaceutical
Aspen
Fresenius Kabi
Pfizer (Hospira)
Sanofi
Aurobindo
Lupin
Dr. Reddy's
Apotex
Cipla
ENDO (Par Pharmaceutical)
Stada Arzneimittel
Krka Group
Nichi-Iko Pharmaceutical
Valeant
Zydus Cadila
Hikma
Pharmaniaga Berhad
Hovid Berhad
Duopharma Biotech
Kotra Pharma
HOE Pharmaceutical
Y.S.P. Industries
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Generic Drugs Market Size 2017-2028
2.1.2 Generic Drugs Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Generic Drugs Segment by Type
2.2.1 Prescription
2.2.2 Non-Prescription Drugs
2.3 Generic Drugs Market Size by Type
2.3.1 Generic Drugs Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Generic Drugs Market Size Market Share by Type (2017-2022)
2.4 Generic Drugs Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Generic Drugs Market Size by Application
2.5.1 Generic Drugs Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Generic Drugs Market Size Market Share by Application (2017-2022)
3 Generic Drugs Market Size by Player
3.1 Generic Drugs Market Size Market Share by Players
3.1.1 Global Generic Drugs Revenue by Players (2020-2022)
3.1.2 Global Generic Drugs Revenue Market Share by Players (2020-2022)
3.2 Global Generic Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Generic Drugs by Regions
4.1 Generic Drugs Market Size by Regions (2017-2022)
4.2 Americas Generic Drugs Market Size Growth (2017-2022)
4.3 APAC Generic Drugs Market Size Growth (2017-2022)
4.4 Europe Generic Drugs Market Size Growth (2017-2022)
4.5 Middle East & Africa Generic Drugs Market Size Growth (2017-2022)
5 Americas
5.1 Americas Generic Drugs Market Size by Country (2017-2022)
5.2 Americas Generic Drugs Market Size by Type (2017-2022)
5.3 Americas Generic Drugs Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Generic Drugs Market Size by Region (2017-2022)
6.2 APAC Generic Drugs Market Size by Type (2017-2022)
6.3 APAC Generic Drugs Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Generic Drugs by Country (2017-2022)
7.2 Europe Generic Drugs Market Size by Type (2017-2022)
7.3 Europe Generic Drugs Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Generic Drugs by Region (2017-2022)
8.2 Middle East & Africa Generic Drugs Market Size by Type (2017-2022)
8.3 Middle East & Africa Generic Drugs Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Generic Drugs Market Forecast
10.1 Global Generic Drugs Forecast by Regions (2023-2028)
10.1.1 Global Generic Drugs Forecast by Regions (2023-2028)
10.1.2 Americas Generic Drugs Forecast
10.1.3 APAC Generic Drugs Forecast
10.1.4 Europe Generic Drugs Forecast
10.1.5 Middle East & Africa Generic Drugs Forecast
10.2 Americas Generic Drugs Forecast by Country (2023-2028)
10.2.1 United States Generic Drugs Market Forecast
10.2.2 Canada Generic Drugs Market Forecast
10.2.3 Mexico Generic Drugs Market Forecast
10.2.4 Brazil Generic Drugs Market Forecast
10.3 APAC Generic Drugs Forecast by Region (2023-2028)
10.3.1 China Generic Drugs Market Forecast
10.3.2 Japan Generic Drugs Market Forecast
10.3.3 Korea Generic Drugs Market Forecast
10.3.4 Southeast Asia Generic Drugs Market Forecast
10.3.5 India Generic Drugs Market Forecast
10.3.6 Australia Generic Drugs Market Forecast
10.4 Europe Generic Drugs Forecast by Country (2023-2028)
10.4.1 Germany Generic Drugs Market Forecast
10.4.2 France Generic Drugs Market Forecast
10.4.3 UK Generic Drugs Market Forecast
10.4.4 Italy Generic Drugs Market Forecast
10.4.5 Russia Generic Drugs Market Forecast
10.5 Middle East & Africa Generic Drugs Forecast by Region (2023-2028)
10.5.1 Egypt Generic Drugs Market Forecast
10.5.2 South Africa Generic Drugs Market Forecast
10.5.3 Israel Generic Drugs Market Forecast
10.5.4 Turkey Generic Drugs Market Forecast
10.5.5 GCC Countries Generic Drugs Market Forecast
10.6 Global Generic Drugs Forecast by Type (2023-2028)
10.7 Global Generic Drugs Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Teva
11.1.1 Teva Company Information
11.1.2 Teva Generic Drugs Product Offered
11.1.3 Teva Generic Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Teva Main Business Overview
11.1.5 Teva Latest Developments
11.2 Novartis - Sandoz
11.2.1 Novartis - Sandoz Company Information
11.2.2 Novartis - Sandoz Generic Drugs Product Offered
11.2.3 Novartis - Sandoz Generic Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Novartis - Sandoz Main Business Overview
11.2.5 Novartis - Sandoz Latest Developments
11.3 Mylan
11.3.1 Mylan Company Information
11.3.2 Mylan Generic Drugs Product Offered
11.3.3 Mylan Generic Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Mylan Main Business Overview
11.3.5 Mylan Latest Developments
11.4 Sun Pharmaceutical
11.4.1 Sun Pharmaceutical Company Information
11.4.2 Sun Pharmaceutical Generic Drugs Product Offered
11.4.3 Sun Pharmaceutical Generic Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Sun Pharmaceutical Main Business Overview
11.4.5 Sun Pharmaceutical Latest Developments
11.5 Aspen
11.5.1 Aspen Company Information
11.5.2 Aspen Generic Drugs Product Offered
11.5.3 Aspen Generic Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Aspen Main Business Overview
11.5.5 Aspen Latest Developments
11.6 Fresenius Kabi
11.6.1 Fresenius Kabi Company Information
11.6.2 Fresenius Kabi Generic Drugs Product Offered
11.6.3 Fresenius Kabi Generic Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Fresenius Kabi Main Business Overview
11.6.5 Fresenius Kabi Latest Developments
11.7 Pfizer (Hospira)
11.7.1 Pfizer (Hospira) Company Information
11.7.2 Pfizer (Hospira) Generic Drugs Product Offered
11.7.3 Pfizer (Hospira) Generic Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Pfizer (Hospira) Main Business Overview
11.7.5 Pfizer (Hospira) Latest Developments
11.8 Sanofi
11.8.1 Sanofi Company Information
11.8.2 Sanofi Generic Drugs Product Offered
11.8.3 Sanofi Generic Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Sanofi Main Business Overview
11.8.5 Sanofi Latest Developments
11.9 Aurobindo
11.9.1 Aurobindo Company Information
11.9.2 Aurobindo Generic Drugs Product Offered
11.9.3 Aurobindo Generic Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Aurobindo Main Business Overview
11.9.5 Aurobindo Latest Developments
11.10 Lupin
11.10.1 Lupin Company Information
11.10.2 Lupin Generic Drugs Product Offered
11.10.3 Lupin Generic Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Lupin Main Business Overview
11.10.5 Lupin Latest Developments
11. Dr. Reddy's
11.11.1 Dr. Reddy's Company Information
11.11.2 Dr. Reddy's Generic Drugs Product Offered
11.11.3 Dr. Reddy's Generic Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Dr. Reddy's Main Business Overview
11.11.5 Dr. Reddy's Latest Developments
11.12 Apotex
11.12.1 Apotex Company Information
11.12.2 Apotex Generic Drugs Product Offered
11.12.3 Apotex Generic Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Apotex Main Business Overview
11.12.5 Apotex Latest Developments
11.13 Cipla
11.13.1 Cipla Company Information
11.13.2 Cipla Generic Drugs Product Offered
11.13.3 Cipla Generic Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Cipla Main Business Overview
11.13.5 Cipla Latest Developments
11.14 ENDO (Par Pharmaceutical)
11.14.1 ENDO (Par Pharmaceutical) Company Information
11.14.2 ENDO (Par Pharmaceutical) Generic Drugs Product Offered
11.14.3 ENDO (Par Pharmaceutical) Generic Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 ENDO (Par Pharmaceutical) Main Business Overview
11.14.5 ENDO (Par Pharmaceutical) Latest Developments
11.15 Stada Arzneimittel
11.15.1 Stada Arzneimittel Company Information
11.15.2 Stada Arzneimittel Generic Drugs Product Offered
11.15.3 Stada Arzneimittel Generic Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 Stada Arzneimittel Main Business Overview
11.15.5 Stada Arzneimittel Latest Developments
11.16 Krka Group
11.16.1 Krka Group Company Information
11.16.2 Krka Group Generic Drugs Product Offered
11.16.3 Krka Group Generic Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.16.4 Krka Group Main Business Overview
11.16.5 Krka Group Latest Developments
11.17 Nichi-Iko Pharmaceutical
11.17.1 Nichi-Iko Pharmaceutical Company Information
11.17.2 Nichi-Iko Pharmaceutical Generic Drugs Product Offered
11.17.3 Nichi-Iko Pharmaceutical Generic Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.17.4 Nichi-Iko Pharmaceutical Main Business Overview
11.17.5 Nichi-Iko Pharmaceutical Latest Developments
11.18 Valeant
11.18.1 Valeant Company Information
11.18.2 Valeant Generic Drugs Product Offered
11.18.3 Valeant Generic Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.18.4 Valeant Main Business Overview
11.18.5 Valeant Latest Developments
11.19 Zydus Cadila
11.19.1 Zydus Cadila Company Information
11.19.2 Zydus Cadila Generic Drugs Product Offered
11.19.3 Zydus Cadila Generic Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.19.4 Zydus Cadila Main Business Overview
11.19.5 Zydus Cadila Latest Developments
11.20 Hikma
11.20.1 Hikma Company Information
11.20.2 Hikma Generic Drugs Product Offered
11.20.3 Hikma Generic Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.20.4 Hikma Main Business Overview
11.20.5 Hikma Latest Developments
11.21 Pharmaniaga Berhad
11.21.1 Pharmaniaga Berhad Company Information
11.21.2 Pharmaniaga Berhad Generic Drugs Product Offered
11.21.3 Pharmaniaga Berhad Generic Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.21.4 Pharmaniaga Berhad Main Business Overview
11.21.5 Pharmaniaga Berhad Latest Developments
11.22 Hovid Berhad
11.22.1 Hovid Berhad Company Information
11.22.2 Hovid Berhad Generic Drugs Product Offered
11.22.3 Hovid Berhad Generic Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.22.4 Hovid Berhad Main Business Overview
11.22.5 Hovid Berhad Latest Developments
11.23 Duopharma Biotech
11.23.1 Duopharma Biotech Company Information
11.23.2 Duopharma Biotech Generic Drugs Product Offered
11.23.3 Duopharma Biotech Generic Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.23.4 Duopharma Biotech Main Business Overview
11.23.5 Duopharma Biotech Latest Developments
11.24 Kotra Pharma
11.24.1 Kotra Pharma Company Information
11.24.2 Kotra Pharma Generic Drugs Product Offered
11.24.3 Kotra Pharma Generic Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.24.4 Kotra Pharma Main Business Overview
11.24.5 Kotra Pharma Latest Developments
11.25 HOE Pharmaceutical
11.25.1 HOE Pharmaceutical Company Information
11.25.2 HOE Pharmaceutical Generic Drugs Product Offered
11.25.3 HOE Pharmaceutical Generic Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.25.4 HOE Pharmaceutical Main Business Overview
11.25.5 HOE Pharmaceutical Latest Developments
11.26 Y.S.P. Industries
11.26.1 Y.S.P. Industries Company Information
11.26.2 Y.S.P. Industries Generic Drugs Product Offered
11.26.3 Y.S.P. Industries Generic Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.26.4 Y.S.P. Industries Main Business Overview
11.26.5 Y.S.P. Industries Latest Developments
12 Research Findings and Conclusion
List of Tables
Table 1. Generic Drugs Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Prescription
Table 3. Major Players of Non-Prescription Drugs
Table 4. Generic Drugs Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Generic Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Generic Drugs Market Size Market Share by Type (2017-2022)
Table 7. Generic Drugs Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Generic Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Generic Drugs Market Size Market Share by Application (2017-2022)
Table 10. Global Generic Drugs Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Generic Drugs Revenue Market Share by Player (2020-2022)
Table 12. Generic Drugs Key Players Head office and Products Offered
Table 13. Generic Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Generic Drugs Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Generic Drugs Market Size Market Share by Regions (2017-2022)
Table 18. Americas Generic Drugs Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Generic Drugs Market Size Market Share by Country (2017-2022)
Table 20. Americas Generic Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Generic Drugs Market Size Market Share by Type (2017-2022)
Table 22. Americas Generic Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Generic Drugs Market Size Market Share by Application (2017-2022)
Table 24. APAC Generic Drugs Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Generic Drugs Market Size Market Share by Region (2017-2022)
Table 26. APAC Generic Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Generic Drugs Market Size Market Share by Type (2017-2022)
Table 28. APAC Generic Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Generic Drugs Market Size Market Share by Application (2017-2022)
Table 30. Europe Generic Drugs Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Generic Drugs Market Size Market Share by Country (2017-2022)
Table 32. Europe Generic Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Generic Drugs Market Size Market Share by Type (2017-2022)
Table 34. Europe Generic Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Generic Drugs Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Generic Drugs Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Generic Drugs Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Generic Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Generic Drugs Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Generic Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Generic Drugs Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Generic Drugs
Table 43. Key Market Challenges & Risks of Generic Drugs
Table 44. Key Industry Trends of Generic Drugs
Table 45. Global Generic Drugs Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Generic Drugs Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Generic Drugs Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Generic Drugs Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Generic Drugs Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Generic Drugs Market Size Market Share Forecast by Application (2023-2028)
Table 51. Teva Details, Company Type, Generic Drugs Area Served and Its Competitors
Table 52. Teva Generic Drugs Product Offered
Table 53. Teva Generic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. Teva Main Business
Table 55. Teva Latest Developments
Table 56. Novartis - Sandoz Details, Company Type, Generic Drugs Area Served and Its Competitors
Table 57. Novartis - Sandoz Generic Drugs Product Offered
Table 58. Novartis - Sandoz Main Business
Table 59. Novartis - Sandoz Generic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Novartis - Sandoz Latest Developments
Table 61. Mylan Details, Company Type, Generic Drugs Area Served and Its Competitors
Table 62. Mylan Generic Drugs Product Offered
Table 63. Mylan Main Business
Table 64. Mylan Generic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Mylan Latest Developments
Table 66. Sun Pharmaceutical Details, Company Type, Generic Drugs Area Served and Its Competitors
Table 67. Sun Pharmaceutical Generic Drugs Product Offered
Table 68. Sun Pharmaceutical Main Business
Table 69. Sun Pharmaceutical Generic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Sun Pharmaceutical Latest Developments
Table 71. Aspen Details, Company Type, Generic Drugs Area Served and Its Competitors
Table 72. Aspen Generic Drugs Product Offered
Table 73. Aspen Main Business
Table 74. Aspen Generic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Aspen Latest Developments
Table 76. Fresenius Kabi Details, Company Type, Generic Drugs Area Served and Its Competitors
Table 77. Fresenius Kabi Generic Drugs Product Offered
Table 78. Fresenius Kabi Main Business
Table 79. Fresenius Kabi Generic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. Fresenius Kabi Latest Developments
Table 81. Pfizer (Hospira) Details, Company Type, Generic Drugs Area Served and Its Competitors
Table 82. Pfizer (Hospira) Generic Drugs Product Offered
Table 83. Pfizer (Hospira) Main Business
Table 84. Pfizer (Hospira) Generic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. Pfizer (Hospira) Latest Developments
Table 86. Sanofi Details, Company Type, Generic Drugs Area Served and Its Competitors
Table 87. Sanofi Generic Drugs Product Offered
Table 88. Sanofi Main Business
Table 89. Sanofi Generic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. Sanofi Latest Developments
Table 91. Aurobindo Details, Company Type, Generic Drugs Area Served and Its Competitors
Table 92. Aurobindo Generic Drugs Product Offered
Table 93. Aurobindo Main Business
Table 94. Aurobindo Generic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 95. Aurobindo Latest Developments
Table 96. Lupin Details, Company Type, Generic Drugs Area Served and Its Competitors
Table 97. Lupin Generic Drugs Product Offered
Table 98. Lupin Main Business
Table 99. Lupin Generic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 100. Lupin Latest Developments
Table 101. Dr. Reddy's Details, Company Type, Generic Drugs Area Served and Its Competitors
Table 102. Dr. Reddy's Generic Drugs Product Offered
Table 103. Dr. Reddy's Generic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 104. Dr. Reddy's Main Business
Table 105. Dr. Reddy's Latest Developments
Table 106. Apotex Details, Company Type, Generic Drugs Area Served and Its Competitors
Table 107. Apotex Generic Drugs Product Offered
Table 108. Apotex Main Business
Table 109. Apotex Generic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 110. Apotex Latest Developments
Table 111. Cipla Details, Company Type, Generic Drugs Area Served and Its Competitors
Table 112. Cipla Generic Drugs Product Offered
Table 113. Cipla Main Business
Table 114. Cipla Generic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 115. Cipla Latest Developments
Table 116. ENDO (Par Pharmaceutical) Details, Company Type, Generic Drugs Area Served and Its Competitors
Table 117. ENDO (Par Pharmaceutical) Generic Drugs Product Offered
Table 118. ENDO (Par Pharmaceutical) Main Business
Table 119. ENDO (Par Pharmaceutical) Generic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 120. ENDO (Par Pharmaceutical) Latest Developments
Table 121. Stada Arzneimittel Details, Company Type, Generic Drugs Area Served and Its Competitors
Table 122. Stada Arzneimittel Generic Drugs Product Offered
Table 123. Stada Arzneimittel Main Business
Table 124. Stada Arzneimittel Generic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 125. Stada Arzneimittel Latest Developments
Table 126. Krka Group Details, Company Type, Generic Drugs Area Served and Its Competitors
Table 127. Krka Group Generic Drugs Product Offered
Table 128. Krka Group Main Business
Table 129. Krka Group Generic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 130. Krka Group Latest Developments
Table 131. Nichi-Iko Pharmaceutical Details, Company Type, Generic Drugs Area Served and Its Competitors
Table 132. Nichi-Iko Pharmaceutical Generic Drugs Product Offered
Table 133. Nichi-Iko Pharmaceutical Main Business
Table 134. Nichi-Iko Pharmaceutical Generic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 135. Nichi-Iko Pharmaceutical Latest Developments
Table 136. Valeant Details, Company Type, Generic Drugs Area Served and Its Competitors
Table 137. Valeant Generic Drugs Product Offered
Table 138. Valeant Main Business
Table 139. Valeant Generic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 140. Valeant Latest Developments
Table 141. Zydus Cadila Details, Company Type, Generic Drugs Area Served and Its Competitors
Table 142. Zydus Cadila Generic Drugs Product Offered
Table 143. Zydus Cadila Main Business
Table 144. Zydus Cadila Generic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 145. Zydus Cadila Latest Developments
Table 146. Hikma Details, Company Type, Generic Drugs Area Served and Its Competitors
Table 147. Hikma Generic Drugs Product Offered
Table 148. Hikma Main Business
Table 149. Hikma Generic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 150. Hikma Latest Developments
Table 151. Pharmaniaga Berhad Details, Company Type, Generic Drugs Area Served and Its Competitors
Table 152. Pharmaniaga Berhad Generic Drugs Product Offered
Table 153. Pharmaniaga Berhad Generic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 154. Pharmaniaga Berhad Main Business
Table 155. Pharmaniaga Berhad Latest Developments
Table 156. Hovid Berhad Details, Company Type, Generic Drugs Area Served and Its Competitors
Table 157. Hovid Berhad Generic Drugs Product Offered
Table 158. Hovid Berhad Main Business
Table 159. Hovid Berhad Generic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 160. Hovid Berhad Latest Developments
Table 161. Duopharma Biotech Details, Company Type, Generic Drugs Area Served and Its Competitors
Table 162. Duopharma Biotech Generic Drugs Product Offered
Table 163. Duopharma Biotech Main Business
Table 164. Duopharma Biotech Generic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 165. Duopharma Biotech Latest Developments
Table 166. Kotra Pharma Details, Company Type, Generic Drugs Area Served and Its Competitors
Table 167. Kotra Pharma Generic Drugs Product Offered
Table 168. Kotra Pharma Main Business
Table 169. Kotra Pharma Generic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 170. Kotra Pharma Latest Developments
Table 171. HOE Pharmaceutical Details, Company Type, Generic Drugs Area Served and Its Competitors
Table 172. HOE Pharmaceutical Generic Drugs Product Offered
Table 173. HOE Pharmaceutical Main Business
Table 174. HOE Pharmaceutical Generic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 175. HOE Pharmaceutical Latest Developments
Table 176. Y.S.P. Industries Details, Company Type, Generic Drugs Area Served and Its Competitors
Table 177. Y.S.P. Industries Generic Drugs Product Offered
Table 178. Y.S.P. Industries Main Business
Table 179. Y.S.P. Industries Generic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 180. Y.S.P. Industries Latest Developments
List of Figures
Figure 1. Generic Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Generic Drugs Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Generic Drugs Market Size Market Share by Type in 2021
Figure 7. Generic Drugs in Hospital
Figure 8. Global Generic Drugs Market: Hospital (2017-2022) & ($ Millions)
Figure 9. Generic Drugs in Clinic
Figure 10. Global Generic Drugs Market: Clinic (2017-2022) & ($ Millions)
Figure 11. Generic Drugs in Others
Figure 12. Global Generic Drugs Market: Others (2017-2022) & ($ Millions)
Figure 13. Global Generic Drugs Market Size Market Share by Application in 2021
Figure 14. Global Generic Drugs Revenue Market Share by Player in 2021
Figure 15. Global Generic Drugs Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Generic Drugs Market Size 2017-2022 ($ Millions)
Figure 17. APAC Generic Drugs Market Size 2017-2022 ($ Millions)
Figure 18. Europe Generic Drugs Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Generic Drugs Market Size 2017-2022 ($ Millions)
Figure 20. Americas Generic Drugs Value Market Share by Country in 2021
Figure 21. Americas Generic Drugs Consumption Market Share by Type in 2021
Figure 22. Americas Generic Drugs Market Size Market Share by Application in 2021
Figure 23. United States Generic Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Generic Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Generic Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Generic Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Generic Drugs Market Size Market Share by Region in 2021
Figure 28. APAC Generic Drugs Market Size Market Share by Application in 2021
Figure 29. China Generic Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Generic Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Generic Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Generic Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Generic Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Generic Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Generic Drugs Market Size Market Share by Country in 2021
Figure 36. Europe Generic Drugs Market Size Market Share by Type in 2021
Figure 37. Europe Generic Drugs Market Size Market Share by Application in 2021
Figure 38. Germany Generic Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Generic Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Generic Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Generic Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Generic Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Generic Drugs Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Generic Drugs Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Generic Drugs Market Size Market Share by Application in 2021
Figure 46. Egypt Generic Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Generic Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Generic Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Generic Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Generic Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Generic Drugs Market Size 2023-2028 ($ Millions)
Figure 52. APAC Generic Drugs Market Size 2023-2028 ($ Millions)
Figure 53. Europe Generic Drugs Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Generic Drugs Market Size 2023-2028 ($ Millions)
Figure 55. United States Generic Drugs Market Size 2023-2028 ($ Millions)
Figure 56. Canada Generic Drugs Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Generic Drugs Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Generic Drugs Market Size 2023-2028 ($ Millions)
Figure 59. China Generic Drugs Market Size 2023-2028 ($ Millions)
Figure 60. Japan Generic Drugs Market Size 2023-2028 ($ Millions)
Figure 61. Korea Generic Drugs Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Generic Drugs Market Size 2023-2028 ($ Millions)
Figure 63. India Generic Drugs Market Size 2023-2028 ($ Millions)
Figure 64. Australia Generic Drugs Market Size 2023-2028 ($ Millions)
Figure 65. Germany Generic Drugs Market Size 2023-2028 ($ Millions)
Figure 66. France Generic Drugs Market Size 2023-2028 ($ Millions)
Figure 67. UK Generic Drugs Market Size 2023-2028 ($ Millions)
Figure 68. Italy Generic Drugs Market Size 2023-2028 ($ Millions)
Figure 69. Russia Generic Drugs Market Size 2023-2028 ($ Millions)
Figure 70. Spain Generic Drugs Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Generic Drugs Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Generic Drugs Market Size 2023-2028 ($ Millions)
Figure 73. Israel Generic Drugs Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Generic Drugs Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Generic Drugs Market Size 2023-2028 ($ Millions)
